Weekly Paclitaxel for Recurrent Ovarian Cancer: Does Weekly Administration During Primary Therapy Impact Efficacy and Toxicity at Recurrence?
AuthID
P-00W-5NX
P-00W-5NX
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service